Zimbabwe has declined a significant US health deal worth 367 million US dollars (272 million pounds) spanning five years over Washington's request for sensitive biological samples.
The decision was revealed after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesman later stated that the US was seeking biological samples for scientific study and commercial gain but was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for more negotiations to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance openness and responsibility.
Based on reports, 16 African countries have so far agreed to similar agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to share its genetic material and health information over an extended period, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," his statement read.
"Put simply, our country would supply the basic resources for scientific discovery without any assurance that the end products would be accessible to our population should a new pandemic emerge."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining frameworks previously set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This system is designed to ensure that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future co-operation could be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks should continue considering much of the country's Aids initiatives depended on foreign aid.
"In cases where technical issues arise, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group added.
This impasse underscores the ongoing tensions between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.